Originally a maker of photo films, Fujifilm Holdings Corp. has been expanding its medical equipment and pharma businesses recent years. In November 2014, the company said it plans to invest around JPY400-500 billion ($3.33-4.16 billion) in strategic M&A over the coming three years. It also highlighted healthcare, highly functional materials and the documents business as its most promising growth units.
The Japanese firm will disclose the impact of the purchase on its consolidated financial results for the fiscal year ending...
Welcome to Scrip
Create an account to read this article
Already a subscriber?